Clinical trial Recruiting at 2 sites Interventional Ages 21 to 75

Using a new device to improve biofeedback therapy for constipation patients

Official title: Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients

Run by The California Medical Innovations Institute, Inc. · NCT05807321 · Data updated 2026-11-12

This study is testing a new device to see if it can help doctors figure out which constipation patients will benefit from biofeedback therapy.

Quick facts

Study typeInterventional
Ages21 Years to 75 Years
SexAll
Enrollment24 (estimated)
SponsorThe California Medical Innovations Institute, Inc.
Academic / other
Locations2 sites (San Diego, California and 1 other locations)
StatusRecruiting
StartedOctober 3, 2023
Main results expectedJanuary 1, 2027
Study endsMarch 31, 2027
Registry record updatedOctober 21, 2025
Trial IDNCT05807321 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21-75 who have been diagnosed with obstructed defecation or dyssynergia.

Probably not a fit

Patients with fecal incontinence, prior anorectal surgery, or severe cardiovascular disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of a novel device called Fecobionics to assess anorectal function in patients with pelvic floor dyssynergia, a condition that contributes to constipation. The device records physiological parameters during defecation and helps monitor the effectiveness of biofeedback therapy. Participants will perform various motions while the device is inserted, allowing researchers to gather detailed data that may predict treatment outcomes. The goal is to identify which patients are likely to benefit from biofeedback therapy before treatment begins.

Why it matters

Potential benefit: If successful, this approach could lead to more effective treatments for patients suffering from constipation due to dyssynergia.

How similar studies have gone: While the use of biofeedback therapy is established, the specific application of Fecobionics for this purpose is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject must provide written informed consent.
2. Age between 21-75 years.
3. Subjects must fulfill the criteria for obstructed defecation/dyssynergia and enter the BFT at UCSD or Scripps.

Exclusion Criteria:

1. Female who is pregnant or lactating.
2. Prior abdominal or anorectal surgery or bowel resection.
3. Diagnosis of fecal incontinence, any anorectal symptoms and drug use that affect anorectal function.
4. Confirmed or suspected COVID-19 infection.
5. Severe cardiovascular disease.
6. Subjects not willing to consent and undergo the specified tests in this study.
7. Other exclusions, that in the opinion of the investigator, the volunteer is not a suitable subject for the study.

Where it's running

  • California Medical Innovations Institute
    San Diego, California, United States
    Recruiting
  • Digestive Health Center- Augusta University
    Augusta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.